Novel Therapies in Oncology: An Individualized Approach

Author(s): Stephanie Gregory, MS, FNP-C, BMTCN, Margaret Kelley, MSN, APN, FNP-BC, OCN, Tanya Lalani, DNP, NP, AOCNP

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 0.75

Expires Sep 01, 2023

Topics: Hematology/Oncology, Pharmacology

Role: APRN, Staff

Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

This article reviews novel therapies in oncology which have made a profound difference in the treatment of cancer. The new approaches described include immune checkpoint inhibitors, antibody-drug conjugates, protein kinase inhibitors, bispecific antibodies and tumor-treating fields. The article explains each agent’s mechanisms of action and the management of adverse events that require critical care interventions.


  • Explain novel therapies in oncology and their mechanisms of action
  • Describe potential adverse events related to novel therapies in oncology that may require critical care team management
  • Identify patient care considerations when caring for a patient with a tumor treating fields device

Continuing Education Disclosure Statement

Successful Completion

Learners must attend/view/read the entire activity and complete the associated evaluation to be awarded the contact hours or CERP. No partial credit will be awarded.


This activity has been reviewed by the Nurse Planner. It has been determined that the material presented here shows no bias. No conflicts of interest have been identified for any individual with the ability to influence the content of this activity. Accreditation refers to recognition of continuing education only and does not imply AACN or ANCC approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity.


The American Association of Critical-Care Nurses (AACN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's (ANCC's) Commission on Accreditation, ANCC Provider Number 0012. AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing (CBRN), California Provider number CEP 1036. This activity is approved for 1.00 contact hours.

AACN programming meets the standards for most states that require mandatory continuing education contact hours for license and/or certification renewal. AACN recommends consulting with your state board of nursing or credentialing organization before submitting CE to fulfill continuing education requirements.

Refund Policy

Continuing Education Activities are nonrefundable.